MET and renal carcinoma: We observed that sorafenib-induced DNA damage and apoptotic death of renal cancer cells was indeed downregulated in presence of either the ROS scavenger NAC or the mitochondrial ROS inhibitor MitoQ, and also following c-Met activation.